Mesothelioma News and Research

RSS

Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.

New clinical trial for patients with asbestos-associated lung cancer

The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.

26 Jun 2008

New support for mesothelioma sufferers in Australia

The Asbestos Research Group, offering hope to sufferers of asbestos-related diseases, was launched at The Wesley Research Institute today.

11 Jun 2008

Asbestos-induced lung cancer patients do not appear to benefit from chemotherapy

Adding chemotherapy to established methods of symptom management does not appear to enhance the quality of life or survival of patients suffering from an asbestos-induced form of lung cancer called malignant plural mesothelioma (MPM). These are the results of MS01, a large UK and Australian study published in the Lancet, which set out to assess the potential benefits of combining active symptom control (ASC) with chemotherapy.

18 May 2008

ACTU says 1.5 million workers are exposed to cancer-causing chemicals

According to the Australian Council of Trade Unions (ACTU), exposure to cancer-causing substances at work threatens the health and well being of as many as 1.5 million Australians.

29 Apr 2008

Mouse model for human malignant mesothelioma

Scientists have established a mouse model for human malignant mesothelioma (MM) that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies.

11 Mar 2008

New technology for cancer screening listens for the signs of cancer

Cancer-sensing devices built as cheaply and efficiently as wristwatches - using many of the same operating principles - could change the way clinicians detect, treat and monitor cancer in patients.

18 Sep 2007

First biomarker discovered that predicts prostate cancer outcome

Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.

17 Aug 2007

Amphinase molecule from frog could provide first drug treatment for brain tumours

A synthetic version of a molecule found in the egg cells of the Northern Leopard frog (Rana pipiens) could provide the world with the first drug treatment for brain tumours.

27 Jun 2007

Talcum powder stunts cancer growth

Talcum powder has been used for generations to soothe babies diaper rash and freshen women's faces.

8 Jun 2007

WHO targets workplace related lung cancer, mesothelioma and bladder cancer

According to the World Health Organisation (WHO) more than 200,000 people die each year from cancers related to their workplaces, mainly from inhaling asbestos fibers and second-hand tobacco smoke.

29 Apr 2007

NYU Medical Center partners with Rosetta Genomics to tackle mesothelioma

Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.

24 Apr 2007

Current predictions of future incidence of asbestos-related disease substantially underestimated

The analysis by Dr Mark Clements, from the National Centre for Epidemiology and Population Health, and colleagues shows that the peak number of cases of mesothelioma, a deadly cancer caused by asbestos, will occur four years later and the future total incidence may be in excess of 35 per cent higher than existing models would have predicted.

4 Apr 2007

ESMO explores collaboration to fight cancer on all fronts

Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.

2 Apr 2007

Publication of the National Mesothelioma Framework

People with a chest cancer related to exposure to asbestos will receive a boost today, as a new framework for improving their care is launched by Britain's Health Minister Rosie Winterton.

From Asthma + Lung UK 26 Feb 2007

Combination drug treatment helps beat mesothelioma

People with mesothelioma - a form of cancer associated with asbestos exposure - have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds.

12 Feb 2007

Mesothelioma Applied Research Foundation achieves Federal appropriations for asbestos-cancer research

The Mesothelioma Applied Research Foundation (Meso Foundation) has announced two historic victories in federal research funding to combat the deadly asbestos-related cancer.

16 Aug 2006

Nuclear test study rules out radiation link

A University of Adelaide study has found that cancer rates among Australian men involved in the 1950s British nuclear tests are 23% higher than the general population, but has shown no link between the increased cancer rates and exposure to radiation.

5 Jul 2006